These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32860461)

  • 1. Case report: SARS-CoV-2-induced urticaria or just a concomitance?
    Fida M; Mala R; Pupo L; Dibra A; Nasto K
    Dermatol Ther; 2020 Nov; 33(6):e14250. PubMed ID: 32860461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urticaria in an infant with SARS-CoV-2 positivity.
    Proietti I; Mambrin A; Bernardini N; Tolino E; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14043. PubMed ID: 32697027
    [No Abstract]   [Full Text] [Related]  

  • 3. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
    Criado PR; Pagliari C; Criado RFJ; Marques GF; Belda W
    Dermatol Ther; 2020 Nov; 33(6):e14068. PubMed ID: 32713127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.
    Goudarzi S; Dehghani Firouzabadi F; Dehghani Firouzabadi M; Rezaei N
    Dermatol Ther; 2020 Nov; 33(6):e14266. PubMed ID: 32882081
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia areata in a patient with SARS-Cov-2 infection.
    Sgubbi P; Savoia F; Calderoni O; Longo R; Stinchi C; Tabanelli M
    Dermatol Ther; 2020 Nov; 33(6):e14295. PubMed ID: 32909635
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
    Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
    Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute urticaria preceding other COVID-19-associated manifestations-A case report.
    Chen V; Escandon Brehm J; Bellodi Schmidt F
    Pediatr Dermatol; 2021 Mar; 38(2):455-457. PubMed ID: 33410205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urticaria in the times of COVID-19.
    Kaushik A; Parsad D; Kumaran MS
    Dermatol Ther; 2020 Nov; 33(6):e13817. PubMed ID: 32531079
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.
    Farabi B; Atak MF
    Dermatol Ther; 2020 Nov; 33(6):e14468. PubMed ID: 33112023
    [No Abstract]   [Full Text] [Related]  

  • 11. Urticaria as a first clinical manifestation of COVID-19.
    Veraldi S; Romagnuolo M; Benzecry V
    Eur J Dermatol; 2020 Dec; 30(6):737-738. PubMed ID: 33459263
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus disease 2019 and epidermolysis bullosa: Report of three cases.
    Abdollahimajd F; Youssefian L; Pourani MR; Vahidnezhad H; Uitto J
    Dermatol Ther; 2020 Nov; 33(6):e14194. PubMed ID: 32794270
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe urticarial rash as the initial symptom of COVID-19 infection.
    Pagali S; Parikh RS
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomadesis following COVID-19 infection: Is there a relationship?
    Senturk N; Ozdemir H
    Dermatol Ther; 2020 Nov; 33(6):e14309. PubMed ID: 32935910
    [No Abstract]   [Full Text] [Related]  

  • 16. Urticaria and COVID-19: A review.
    Algaadi SA
    Dermatol Ther; 2020 Nov; 33(6):e14290. PubMed ID: 32902087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
    Martinez MA
    Front Immunol; 2021; 12():635371. PubMed ID: 33777024
    [No Abstract]   [Full Text] [Related]  

  • 18. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia.
    Gunawan C; Angela A; Widysanto A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e372-e373. PubMed ID: 32386435
    [No Abstract]   [Full Text] [Related]  

  • 19. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19.
    Patrì A; Vargas M; Buonanno P; Annunziata MC; Russo D; Staibano S; Servillo G; Fabbrocini G
    Diagn Pathol; 2021 Feb; 16(1):16. PubMed ID: 33632250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urticarial vasculitis in a COVID-19 recovered patient.
    Nasiri S; Dadkhahfar S; Abasifar H; Mortazavi N; Gheisari M
    Int J Dermatol; 2020 Oct; 59(10):1285-1286. PubMed ID: 32880937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.